Skip to main content

Year: 2025

StorageVault Announces Full Exercise of Over-Allotment Option

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES TORONTO, Dec. 04, 2025 (GLOBE NEWSWIRE) — STORAGEVAULT CANADA INC. (“StorageVault”) (SVI-TSX) is pleased to announce that, further to its November 12, November 25, and November 28, 2025 news releases, in connection with the previously announced offering (the “Offering”) of listed senior unsecured hybrid debentures (the “Debentures”), the underwriters have exercised their over-allotment option in full to purchase an additional $7.5 million aggregate principal amount of Debentures at an issuance price of $1,000 per Debenture, for additional gross proceeds to StorageVault of $7.5 million. As a result, the total gross proceeds of the Offering were $57.5 million. CIBC World Markets Inc. and Scotia Capital Inc. led the syndicate of underwriters...

Continue reading

Tryg nominates Steffen Kragh as new Chair of the Supervisory Board

Chair of the Supervisory Board, Jukka Pertola, will not seek reelection at the coming Annual General Meeting of Tryg A/S in March 2026. Deputy Chair, Steffen Kragh, is nominated as new Chair of the Supervisory Board, and Board member Benedicte Bakke Agerup is nominated as new Deputy Chair of the Supervisory Board.  After nine years on Tryg A/S’ Supervisory Board, the Chair, Jukka Pertola, has announced that he is not seeking reelection at the Annual General Meeting of Tryg A/S in March 2026. Jukka Pertola was elected to the Supervisory Board in 2017 and has since made a profound impact on the Group. In the same period, the Group has doubled its size measured on top and bottom line with multiple successful acquisitions contributing to ensure the Group’s unique position in Scandinavia. The Supervisory Board of Tryg also carried through a...

Continue reading

Information on the total number of voting rights and shares of 74Software share capital as of November 30, 2025

Press Release Information on the total number of voting rights and shares of 74Software share capital as of November 30, 2025 Paris, December 4, 2025 – In accordance with Articles L.233-8 II and R.225-73 I of the French Commercial Code (Code de Commerce) and Article 223-16 of the General Regulations of the Autorité des Marchés Financiers (RGAMF), 74Software hereby informs its shareholders that, as of November 30, 2025:Total number of shares is 29,746,194. Total number of theoretical voting rights is 41,290,909.It is calculated according to the total number of shares with voting rights, including those whose voting rights have been suspended, and is used to declare threshold crossing by shareholders in accordance with Article 223-11 of the RGAMF.Number of exercisable voting rights is 40,809,354.Disclaimer This document is...

Continue reading

Acceleware Ltd. Announces Feasibility Studies for BHP

CALGARY, Alberta, Dec. 04, 2025 (GLOBE NEWSWIRE) — Acceleware® Ltd. (“Acceleware” or the “Company”) (TSX-V: AXE), is pleased to announce two paid feasibility studies for BHP. The studies will assess the techno-economic viability of using Acceleware’s EM Powered Heat for novel mineral processing and drying applications. “Both studies are new and exciting opportunities to demonstrate how our EM Powered Heat technology can transform minerals processing,” said Geoff Clark, Chief Executive Officer. “These innovations align with our strategy to deliver cost-efficient process heat solutions that increase production for the mining sector. Building on strong results from our potash dryer prototype, we’re eager to advance both iron ore drying and heap leach heating to unlock new growth opportunities in mineral processing.” The first study...

Continue reading

SurgePays Adds Three New Subprime Lead Generation Aggregators to Accelerate ProgramBenefits.com Activations

Initiatives aim to convert customer acquisition into a profit center while supporting growth across both subsidized and prepaid wireless channels BARTLETT, Tenn., Dec. 04, 2025 (GLOBE NEWSWIRE) — SurgePays, Inc. (NASDAQ: SURG), a wireless and fintech point of sale company, today announced the addition of three lead generation aggregators to its ProgramBenefits platform. These integrations continue the expansion into subprime consumers seeking wireless service, credit solutions, and everyday benefit programs. The three aggregators add meaningful momentum to the ProgramBenefits initiative by routing an expected 10,000 new subprime leads per day at full scale. The consumer data intake platform is built to lower wireless subscriber acquisition costs while creating multiple revenue opportunities from each consumer. All incoming traffic...

Continue reading

Stantec awarded second phase of European Commission’s Global Technical Assistance Facility for Sustainable Energy

BRUSSELS, Dec. 04, 2025 (GLOBE NEWSWIRE) — TSX, NYSE:STN Stantec, a global leader in sustainable design and engineering, has been awarded the second phase of the European Commission’s Global Technical Assistance Facility (TAF) for Sustainable Energy. The €27.7 million (C$45.4 million) new assignment builds on the firm’s successful management of the previous initiative—Sustainable Energy for All—as well as the first phase of the Global TAF. For more than 15 years, Stantec has been a key partner in advancing the European Union’s external energy and climate objectives. Stantec’s contract for the second phase of the Global TAF will run until October 2028. Accelerating the global energy transition The Global TAF for Sustainable Energy is the European Commission’s flagship and largest initiative to support EU partner countries in scaling...

Continue reading

Propanc Biopharma Investigates “Mesenchymal Drift” to Reverse Chronic Diseases Defined by Altos Labs

Joint Research Team Focusing on Impact of PRP Reversal of EMT Pathways as Central Role MELBOURNE, Australia, Dec. 04, 2025 (GLOBE NEWSWIRE) — Propanc Biopharma, Inc. (Nasdaq: PPCB) (“Propanc” or the “Company”), a biopharmaceutical company developing novel treatments for chronic diseases such as recurrent and metastatic cancer, today announced plans to investigate the phenomenon of “mesenchymal drift”—an emerging area of research that may help unlock the mechanisms behind the reversal of chronic diseases. The concept, advanced by leaders in the field including Altos Labs, Inc., aligns with Propanc’s expanding research efforts into how its lead product candidate, PRP, may influence the epithelial-to-mesenchymal transition (EMT) and related pathways central not only to cancer progression but also other chronic diseases. Fibrosis,...

Continue reading

Senti Bio to Host Conference Call and Webcast to Discuss SENTI-202 Clinical Data Being Presented at the American Society of Hematology (ASH) Annual Meeting 2025 on Tuesday, December 9th at 8:00 AM ET

SOUTH SAN FRANCISCO, Calif., Dec. 04, 2025 (GLOBE NEWSWIRE) — Senti Biosciences, Inc. (Nasdaq: SNTI) (“Senti Bio”), a clinical-stage biotechnology company developing next-generation cell and gene therapies using its proprietary Gene Circuit platform, today announced it will host a conference call and webcast to discuss updated clinical results from SENTI-202 being presented at the ASH Annual Meeting on Tuesday, December 9, 2025 at 8:00 AM ET. The call will be hosted by Timothy Lu, MD, PhD, Chief Executive Officer and Co-Founder, and Kanya Rajangam, MD, PhD, President, Head of R&D and Chief Medical Officer, of Senti Bio, who will be joined by Nosha Farhadfar, MD, Hematologist and Bone Marrow Transplant Physician, Sarah Cannon Transplant & Cellular Therapy Program at Methodist Hospital which conducts research through Sarah...

Continue reading

MediPharm Labs Completes First Shipment to France

TORONTO, Dec. 04, 2025 (GLOBE NEWSWIRE) — MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) (“MediPharm”, “MediPharm Labs” or the “Company”), a pharmaceutical company specialized in precision-based cannabinoids, is pleased to announce the completion of the Company’s first shipment to France. This milestone follows a production agreement with an international medicinal cannabis organization. This strategic collaboration strengthens MediPharm’s position as a trusted supplier of pharmaceutical-grade cannabis products and demonstrates the Company’s ability to meet stringent European regulatory standards. The French medicinal cannabis market is projected to experience significant growth over the coming years. Conservative estimates place the market at US$187.6 million by...

Continue reading

Portillo’s Launches Season of Surprises Holiday Promotion Throughout December

Members of Portillo’s Perks, the company’s loyalty program, can enjoy freebies and special deals now through the end of the year CHICAGO, Dec. 04, 2025 (GLOBE NEWSWIRE) — With the holiday season in full swing, Portillo’s is spreading cheer and delicious deals to members of its loyalty program, Portillo’s Perks, with a variety of holiday promotions throughout the month. Portillo’s Season of Surprises will gift free menu items, discounted merchandise, personalized offers, and exclusive secret menu drops to help Perks members savor the season and make lasting holiday memories with Portillo’s unrivaled Chicago-style staples. “When we launched the Portillo’s Perks loyalty program earlier this year, we set out to surprise and delight our guests with rewarding offers and experiences, and the response has been overwhelmingly positive,”...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.